Clover Biopharmaceuticals, Ltd.
Last verified 2026-05-07. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $3.6Mattributed |
|---|---|
| Latest round | Funding round, $3.6M, 2026-03-27attributed |
| Founded | unknown |
| Headquarters | CHENGDU, F4 |
| Industry | biotechnology |
| Stage | unknown |
| Website | clover.com |
Clover Biopharmaceuticals develops vaccines and biologics using its proprietary Trimer-Tag protein technology to treat infectious and chronic diseases. It serves global health markets needing accessible vaccines and biologic medicines. The Trimer-Tag platform produces native-like trimeric antigens that improve immunogenicity over conventional protein subunits.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-03-27 | Funding round | $3.6M | undisclosed |
Detected tech stack
AddThis, AppNexus, Linkedin Ads, Linkedin Insight Tag, reCAPTCHA, Reddit, RevContent, Google Cloud Storage, Evidon, HubSpot, CrownPeak Universal Consent Platform, Bootstrap
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $3.6M | attributed | sec-edgar named as publisher. No document URL on file. |
| Total raised $3.6M | attributed | sec-edgar named as publisher. No document URL on file. |
| Company existence | self-reported | clover.com, read 2026-05-07 |
| Description | self-reported | clover.com, read 2026-05-07 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $3.6M, 2026-03-27 → Funding round, $3.6M, 2026-03-27, sec-edgar, No document URL on file | Latest round | seed, $3.6M, 2026-03-27 → Funding round, $3.6M, 2026-03-27 | sec-edgar, No document URL on file |
Records begin 2026-09-24. All changes